Grape Cuvée is Maven Genetics' violet-soaked cross of MAC #1 and Garanimals — a grape-forward flower built for the exhale, not the pitch deck. Dense, colorful buds run bold violet into eggplant-purple under a milky trichome coat, streaked with electric-orange stigmas, and the jar reads straight grape syrup with berry trailing behind.
Where It Comes From
Maven Genetics runs a California indoor program built on disciplined pheno hunting, precision cultivation, and meticulous curing — structure, terpene architecture, resin density, and burn quality are all treated as intentional, with only the most expressive genetics making the cut. Grape Cuvée was one of those cuts — a release that's since cycled out of Maven's regular catalog, though its genetics went on to shape two more Maven strains.
The Cross
MAC #1 brings the pedigree side: it's Capulator's own selected cut, the phenotype that built its reputation on citrus, fuel, and cream. Garanimals supplies the other half, tracing back to Grape Pie and Animal Cookies, and it's doing most of the work on both the grape character and the physical weight this flower carries. Maven calls Grape Cuvée a hybrid, and that's the read we go with — though the effects lean heavy enough that an indica-leaning label wouldn't be wrong either.
The buds match the pedigree: bold violet-to-eggplant color, a heavy milky trichome coat, and bright orange hairs threaded through — a look that does a lot of the selling before the jar's even open.
The High Rise Take
Grape Cuvée matters more for what it built than what it was. Maven crossed it into Kush Mints 11 to make Pandora, the third drop in the brand's limited Black Box series, and into Affogato to make Ube Crème, a deep-purple indica that keeps the grape line running. Both are proof the genetics were worth keeping around after the original left rotation. Want the grape-and-cream profile with a minty edge — chase Pandora. Want it fully indica — Ube Crème's the move.
Start low, see how it sits before going back in, and never get behind the wheel after.